Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Nicotinamide and Sevelamer for Phosphatemia Control in Hemodialysis Patients
NCT01011699Phase 3Terminated
- Sponsor
- CHU Amiens-Picardie
- Start
- Jan 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotinamide in hyperphosphatemia, sponsored by CHU Amiens-Picardie. Started Jan 2010; status: terminated.
02
Drugs
nicotinamide
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01011699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011699.